Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

First-in-human phase 0 study of 111in-chx-a”-trastuzumab for her2 tumor imaging

Karen Kurdziel, Esther Mena, Stephen Adler, Yolanda McKinney, Maria Liza Lindenberg, Ismail Baris Turkbey, Karen Wong, Jae-Ho Lee, Chang Paik and Peter Choyke
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1351;
Karen Kurdziel
3Center for Cancer Research/Molecular Imaging Program National Cancer Institute/National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esther Mena
3Center for Cancer Research/Molecular Imaging Program National Cancer Institute/National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Adler
2Clinical Monitoring Research Program/Contrator for NCI Molecular Imaging Program Leidos Biomedical Research Inc./Frederick National Laboratory for Cancer Research Frederick (personnel stationed in Bethesda) MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yolanda McKinney
3Center for Cancer Research/Molecular Imaging Program National Cancer Institute/National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Liza Lindenberg
3Center for Cancer Research/Molecular Imaging Program National Cancer Institute/National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ismail Baris Turkbey
3Center for Cancer Research/Molecular Imaging Program National Cancer Institute/National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen Wong
3Center for Cancer Research/Molecular Imaging Program National Cancer Institute/National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jae-Ho Lee
1Radiology and Imaging/Nuclear Medicine Division Clinical Center/National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chang Paik
1Radiology and Imaging/Nuclear Medicine Division Clinical Center/National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Choyke
3Center for Cancer Research/Molecular Imaging Program National Cancer Institute/National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
First-in-human phase 0 study of 111in-chx-a”-trastuzumab for her2 tumor imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
First-in-human phase 0 study of 111in-chx-a”-trastuzumab for her2 tumor imaging
Karen Kurdziel, Esther Mena, Stephen Adler, Yolanda McKinney, Maria Liza Lindenberg, Ismail Baris Turkbey, Karen Wong, Jae-Ho Lee, Chang Paik, Peter Choyke
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1351;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
First-in-human phase 0 study of 111in-chx-a”-trastuzumab for her2 tumor imaging
Karen Kurdziel, Esther Mena, Stephen Adler, Yolanda McKinney, Maria Liza Lindenberg, Ismail Baris Turkbey, Karen Wong, Jae-Ho Lee, Chang Paik, Peter Choyke
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1351;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

MTA I: Basic Science Posters

  • In Vivo PET/CT neuroimaging of radiolabeled nanocarriers following intranasal drug delivery (INDD): Validation using Ex Vivo PET/CT, gamma counting and autoradiography.
  • 18F-ML10 PET/CT demonstrates therapy-induced apoptosis in murine pancreatic adenocarcinoma
  • Relationship between the dynamic profile of LAT1 probe and tumoral blood flow: comparison study using 18F-FBPA, 18F-FAMT, and 15O-water PET
Show more MTA I: Basic Science Posters

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire